Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration

Details for Australian Patent Application No. 2010201022 (hide)

Owner Teva Women's Health, Inc.

Inventors Bell, Robert G.; Ben-Maimon, Carole S.; Iskold, Beata; Bronnenkant, Lance J.; Hait, Howard; Reape, Kathleen Z.

Agent Davies Collison Cave

Pub. Number AU-B-2010201022

Parent 2004257772

Filing date 17 March 2010

Wipo publication date 8 April 2010

Acceptance publication date 27 September 2012

International Classifications

A61K 31/56 - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/565 - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/57 - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

Event Publications

1 April 2010 Complete Application Filed

8 April 2010 Application Open to Public Inspection

  Published as AU-B-2010201022

10 June 2010 Alteration of Name

  The name of the applicant has been altered to Teva Women's Health, Inc.

27 September 2012 Application Accepted

  Published as AU-B-2010201022

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010201023-Drugs and uses

2010201021-A Structural Panel